Cargando…

Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey

OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Q, Oladapo, OT, Leathersich, S, Vogel, JP, Carroli, G, Lumbiganon, P, Qureshi, Z, Gülmezoglu, AM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697690/
https://www.ncbi.nlm.nih.gov/pubmed/27885772
http://dx.doi.org/10.1111/1471-0528.14400
_version_ 1783280667480555520
author Long, Q
Oladapo, OT
Leathersich, S
Vogel, JP
Carroli, G
Lumbiganon, P
Qureshi, Z
Gülmezoglu, AM
author_facet Long, Q
Oladapo, OT
Leathersich, S
Vogel, JP
Carroli, G
Lumbiganon, P
Qureshi, Z
Gülmezoglu, AM
author_sort Long, Q
collection PubMed
description OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total of 147 health facilities in 15 countries across Africa, Latin America and Asia. POPULATION: Heads of obstetric departments or maternity units. METHODS: Anonymous online and paper‐based survey conducted in 2015. MAIN OUTCOME MEASURES: Availability and use of MgSO (4); availability of a formal clinical protocol for MgSO (4) administration; and MgSO (4) dosing regimens for eclampsia prevention and treatment. RESULTS: Magnesium sulphate and a formal protocol for its administration were reported to be always available in 87.4% and 86.4% of all facilities, respectively. MgSO (4) was used for the treatment of mild pre‐eclampsia, severe pre‐eclampsia and eclampsia in 24.3%, 93.5% and 96.4% of all facilities, respectively. Regarding the treatment of severe pre‐eclampsia, 26.4% and 7.0% of all facilities reported using dosing regimens that were consistent with Zuspan and Pritchard regimens, respectively. Across regions, intramuscular maintenance regimens were more commonly used in the African region (45.7%) than in the Latin American (3.0%) and Asian (22.9%) regions, whereas intravenous maintenance regimens were more often used in the Latin American (94.0%) and Asian (60.0%) regions than in the African region (21.7%). Similar patterns were found for the treatment of eclampsia across regions. CONCLUSIONS: The reported clinical use of MgSO (4) for eclampsia prevention and treatment varied widely, and was largely inconsistent with current international recommendations. TWEETABLE ABSTRACT: MgSO (4) regimens for eclampsia prevention and treatment in many hospitals are inconsistent with international recommendations.
format Online
Article
Text
id pubmed-5697690
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56976902017-11-28 Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey Long, Q Oladapo, OT Leathersich, S Vogel, JP Carroli, G Lumbiganon, P Qureshi, Z Gülmezoglu, AM BJOG General Obstetrics OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO (4)) for eclampsia prevention and treatment in a multi‐country network of health facilities and compare with international recommendations. DESIGN: Cross‐sectional survey. SETTING: A total of 147 health facilities in 15 countries across Africa, Latin America and Asia. POPULATION: Heads of obstetric departments or maternity units. METHODS: Anonymous online and paper‐based survey conducted in 2015. MAIN OUTCOME MEASURES: Availability and use of MgSO (4); availability of a formal clinical protocol for MgSO (4) administration; and MgSO (4) dosing regimens for eclampsia prevention and treatment. RESULTS: Magnesium sulphate and a formal protocol for its administration were reported to be always available in 87.4% and 86.4% of all facilities, respectively. MgSO (4) was used for the treatment of mild pre‐eclampsia, severe pre‐eclampsia and eclampsia in 24.3%, 93.5% and 96.4% of all facilities, respectively. Regarding the treatment of severe pre‐eclampsia, 26.4% and 7.0% of all facilities reported using dosing regimens that were consistent with Zuspan and Pritchard regimens, respectively. Across regions, intramuscular maintenance regimens were more commonly used in the African region (45.7%) than in the Latin American (3.0%) and Asian (22.9%) regions, whereas intravenous maintenance regimens were more often used in the Latin American (94.0%) and Asian (60.0%) regions than in the African region (21.7%). Similar patterns were found for the treatment of eclampsia across regions. CONCLUSIONS: The reported clinical use of MgSO (4) for eclampsia prevention and treatment varied widely, and was largely inconsistent with current international recommendations. TWEETABLE ABSTRACT: MgSO (4) regimens for eclampsia prevention and treatment in many hospitals are inconsistent with international recommendations. John Wiley and Sons Inc. 2016-11-24 2017-11 /pmc/articles/PMC5697690/ /pubmed/27885772 http://dx.doi.org/10.1111/1471-0528.14400 Text en © 2016 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle General Obstetrics
Long, Q
Oladapo, OT
Leathersich, S
Vogel, JP
Carroli, G
Lumbiganon, P
Qureshi, Z
Gülmezoglu, AM
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
title Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
title_full Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
title_fullStr Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
title_full_unstemmed Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
title_short Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
title_sort clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
topic General Obstetrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697690/
https://www.ncbi.nlm.nih.gov/pubmed/27885772
http://dx.doi.org/10.1111/1471-0528.14400
work_keys_str_mv AT longq clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT oladapoot clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT leathersichs clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT vogeljp clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT carrolig clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT lumbiganonp clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT qureshiz clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT gulmezogluam clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey
AT clinicalpracticepatternsontheuseofmagnesiumsulphatefortreatmentofpreeclampsiaandeclampsiaamulticountrysurvey